|
RPA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.363000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.301500E-03 |
| Normal-vs-Stage2 |
2.468000E-02 |
| Normal-vs-Stage3 |
5.804100E-04 |
| Normal-vs-Stage4 |
4.206100E-04 |
| Stage1-vs-Stage2 |
9.109000E-01 |
| Stage1-vs-Stage3 |
3.564200E-01 |
| Stage1-vs-Stage4 |
2.312400E-01 |
| Stage2-vs-Stage3 |
4.681800E-01 |
| Stage2-vs-Stage4 |
3.046600E-01 |
| Stage3-vs-Stage4 |
6.398600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.774300E-04 |
| Normal-vs-AfricanAmerican |
7.823200E-01 |
| Normal-vs-Asian |
1.760210E-02 |
| Caucasian-vs-AfricanAmerican |
4.403900E-02 |
| Caucasian-vs-Asian |
8.749600E-01 |
| AfricanAmerican-vs-Asian |
1.380980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.41359999999924E-05 |
| Normal-vs-Female |
3.963200E-03 |
| Male-vs-Female |
7.493700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.443670E-03 |
| Normal-vs-Age(41-60Yrs) |
3.804100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.780600E-04 |
| Normal-vs-Age(81-100Yrs) |
4.097500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.018000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.394400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.419000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.541800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.036000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.926800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.048190E-01 |
| Classical-VS-Follicular |
2.566400E-02 |
| Classical-VS-Other |
3.627400E-01 |
| Classical-VS-Normal |
1.137730E-02 |
| Tall-VS-Follicular |
9.469600E-01 |
| Tall-VS-Other |
9.326800E-01 |
| Tall-VS-Normal |
9.236200E-04 |
| Follicular-VS-Other |
9.668800E-01 |
| Follicular-VS-Normal |
1.613490E-04 |
| Other-VS-Normal |
5.730200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.426100E-04 |
| Normal-vs-N1 |
2.09539999999064E-05 |
| N0-vs-N1 |
2.603900E-02 |
|
|
